Contact

All Stories

  1. Neuroinflammatory Human Brain Organoids Enable Comprehensive Drug Screening Studies: Fingolimod and its Analogues in Focus

    Article • Current Medicinal Chemistry, July 2026, Bentham Science Publishers

    Alaattin SEN, Prof. Dr. Dr. h.c. Holger Stark

  2. Experimental Models for the Discovery of Novel Anticonvulsant Drugs: Focus on Pentylenetetrazole-Induced Seizures and Associated Memory Deficits

    Article • Current Pharmaceutical Design, May 2020, Bentham Science Publishers

    Prof. Dr. Dr. h.c. Holger Stark, Abdu Adem

  3. Antinociceptive effects of novel histamine H3 and H4 receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse

    Article • British Journal of Pharmacology, May 2018, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  4. Discovery of Pitolisant, the First Marketed Histamine H3 -Receptor Inverse Agonist/Antagonist for Treating Narcolepsy*

    Article • April 2018, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  5. The histamine H4 receptor modulates the differentiation process of human monocyte-derived M1 macrophages and the release of CCL4/MIP-1β from fully differentiated M1 macrophages

    Article • Inflammation Research, March 2018, Springer Science + Business Media

    Prof. Dr. Dr. h.c. Holger Stark

  6. HPV Vaccination: Prevention of Cervical Cancer in Serbia and in Europe

    Article • Acta Facultatis Medicae Naissensis, January 2018, De Gruyter

    Prof. Dr. Dr. h.c. Holger Stark

  7. From Magic Bullet To Magic Pump Gun: Multi-targeting Drugs For Neurodegenerative Diseases

    Article • October 2017, Science Trends

    Prof. Dr. Dr. h.c. Holger Stark

  8. Another Piece Of Puzzle In Adjuvant Treatment Of Inflammatory Diseases With Natural Compounds

    Article • October 2017, Science Trends

    Prof. Dr. Dr. h.c. Holger Stark

  9. Low Field NMR Determination of pKa Values for Hydrophilic Drugs for Students in Medicinal Chemistry

    Article • Magnetochemistry, September 2017, MDPI AG

    Prof. Dr. Dr. h.c. Holger Stark

  10. Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands

    Article • Frontiers in Chemistry, September 2017, Frontiers

    Prof. Dr. Dr. h.c. Holger Stark

  11. Further Developments

    Article • Archiv der Pharmazie, January 2017, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  12. Meet Our Editorial Board Member

    Article • Current Medicinal Chemistry, November 2016, Bentham Science Publishers

    Prof. Dr. Dr. h.c. Holger Stark

  13. Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists

    Article • Drug Design Development and Therapy, November 2016, Dove Medical Press

    Prof. Dr. Dr. h.c. Holger Stark

  14. Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats

    Article • Drug Design Development and Therapy, November 2016, Dove Medical Press

    Prof. Dr. Dr. h.c. Holger Stark, Professor Katarzyna Kiec-Kononowicz

  15. Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases

    Article • Frontiers in Neuroscience, October 2016, Frontiers

    Dr Stefania Butini, Prof. Dr. Dr. h.c. Holger Stark, Dr Simone Brogi

  16. Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases

    Article • Behavioural Brain Research, October 2016, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  17. Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism

    Article • Medicinal Research Reviews, August 2016, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  18. Cherry-picked ligands at histamine receptor subtypes

    Article • Neuropharmacology, July 2016, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  19. Histamine H4 receptor activation alleviates neuropathic pain through differential regulation of ERK, JNK, and P38 MAPK phosphorylation

    Article • Pain, December 2015, Wolters Kluwer Health

    Prof. Dr. Dr. h.c. Holger Stark

  20. Histamine H4 Receptor Antagonists: A New Approach for Tinnitus Treatment?

    Article • Recent Patents on CNS Drug Discovery, July 2015, Bentham Science Publishers

    Prof. Dr. Dr. h.c. Holger Stark

  21. Next Steps in Advancing Publication

    Article • Archiv der Pharmazie, January 2015, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  22. Design, synthesis and evaluation of 2-aminothiazole derivatives as sphingosine kinase inhibitors

    Article • Bioorganic & Medicinal Chemistry, October 2014, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  23. Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands

    Article • Drug Design Development and Therapy, September 2014, Taylor & Francis

    Prof. Dr. Dr. h.c. Holger Stark

  24. Psychostimulants

    Article • July 2014, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  25. Anticonvulsive effect of nonimidazole histamine H3 receptor antagonists

    Article • Behavioural Pharmacology, June 2014, Wolters Kluwer Health

    Prof. Dr. Dr. h.c. Holger Stark

  26. Procognitive Properties of Drugs with Single and Multitargeting H3Receptor Antagonist Activities

    Article • CNS Neuroscience & Therapeutics, May 2014, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  27. Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H3 receptor antagonist ST-1283

    Article • Drug Design Development and Therapy, May 2014, Taylor & Francis

    Prof. Dr. Dr. h.c. Holger Stark

  28. Synthesis of novel dansyl-labeled Celecoxib derivatives

    Article • Tetrahedron Letters, December 2013, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  29. Scaffold variations in amine warhead of histamine H3 receptor antagonists

    Article • Drug Discovery Today Technologies, December 2013, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  30. Polymorphisms and genetic linkage of histamine receptors

    Article • Life Sciences, October 2013, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  31. Histamine H4 Receptor: A Novel Drug Target in Immunoregulation and Inflammation

    Article • January 2013, De Gruyter

    Prof. Dr. Dr. h.c. Holger Stark

  32. Bodilisant—A Novel Fluorescent, Highly Affine Histamine H3 Receptor Ligand

    Article • ACS Medicinal Chemistry Letters, December 2012, American Chemical Society (ACS)

    Prof. Dr. Dr. h.c. Holger Stark

  33. Histamine receptor subtypes a century of rational drug design

    Article • January 2012, Frontiers in Bioscience

    Prof. Dr. Dr. h.c. Holger Stark

  34. Novel Chalcone-Based Fluorescent Human Histamine H3 Receptor Ligands as Pharmacological Tools

    Article • Frontiers in Systems Neuroscience, January 2012, Frontiers

    Prof. Dr. Dr. h.c. Holger Stark

  35. Synthesis of 1,2,3-Triazole Elements in Histamine H3 Receptor Ligands

    Article • Synthesis, July 2011, Thieme Publishing Group

    Prof. Dr. Dr. h.c. Holger Stark

  36. Efficient chromatography-free synthesis of the oxy-analogue of fingolimod

    Article • Tetrahedron Letters, July 2010, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  37. ChemInform Abstract: Dopamine D3 Receptor Ligands with Antagonist Properties

    Article • ChemInform, May 2010, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  38. Kojic Acid Derivatives as Histamine H3 Receptor Ligands

    Article • Chemical and Pharmaceutical Bulletin, January 2010, Pharmaceutical Society of Japan

    Prof. Dr. Dr. h.c. Holger Stark

  39. Histamine H3 Receptors Are Involved in the Protective Effect of Ghrelin against HCl-Induced Gastric Damage in Rats

    Article • Pharmacology, January 2010, Karger Publishers

    Prof. Dr. Dr. h.c. Holger Stark

  40. Histamine H3and H4receptors as novel drug targets

    Article • Expert Opinion on Investigational Drugs, September 2009, Informa Healthcare

    Dr Ekaterini Tiligada, Prof. Dr. Dr. h.c. Holger Stark

  41. Histamine H4receptor antagonism reduces hapten-induced scratching behaviour but not inflammation

    Article • Experimental Dermatology, January 2009, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  42. Drug Discovery

    Article • November 2008, Taylor & Francis

    Prof. Dr. Dr. h.c. Holger Stark

  43. Antitussiva und Expektorantien. Medizinisch-chemische Aspekte

    Article • Pharmazie in unserer Zeit, November 2008, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  44. Histamine H3- Receptor Agonists and Antagonists

    Article • April 2008, Taylor & Francis

    Prof. Dr. Dr. h.c. Holger Stark

  45. W1955 Resveratrol Analogues with Potent Anticarcinogenic Properties

    Article • Gastroenterology, April 2008, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  46. Histamine H3 Receptor Antagonists Go to Clinics

    Article • Biological and Pharmaceutical Bulletin, January 2008, Pharmaceutical Society of Japan

    Prof. Dr. Dr. h.c. Holger Stark

  47. Designs that Enrich Lives: Archiv der Pharmazie 10/2007

    Article • Archiv der Pharmazie, October 2007, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  48. Highly Potent Fluorescence-Tagged Nonimidazole Histamine H3 Receptor Ligands

    Article • ChemMedChem, May 2007, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  49. Medizinische Chemie von Histamin-H2-Rezeptorantagonisten: Klassische Wirkstoffentwicklung

    Article • Pharmazie in unserer Zeit, January 2007, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  50. Neuroprotektives B2 verstärkt die Ablagerung fehlgefalteter Proteine bei C. Huntington und M. Parkinson

    Article • Pharmazie in unserer Zeit, November 2006, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  51. Predicting Compound Selectivity by Self-Organizing Maps: Cross-Activities of Metabotropic Glutamate Receptor Antagonists

    Article • ChemMedChem, October 2006, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  52. Editorial: Impact and other Improvements

    Article • Archiv der Pharmazie, July 2006, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  53. From Target to Lead Synthesis

    Article • June 2006, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  54. Kaffee gegen Morbus Parkinson?

    Article • Pharmazie in unserer Zeit, May 2006, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  55. Retinazellen gegen Morbus Parkinson

    Article • Pharmazie in unserer Zeit, May 2006, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  56. Editorial: Pharmazie in unserer Zeit 3/2006

    Article • Pharmazie in unserer Zeit, May 2006, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  57. Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities

    Article • Bioorganic & Medicinal Chemistry Letters, April 2006, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  58. Komplexe Regulationen bei Dopamin-D2-Rezeptoren

    Article • Pharmazie in unserer Zeit, January 2006, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  59. Neurotransmitters, Agonists, and Antagonists

    Article • October 2005, Taylor & Francis

    Prof. Dr. Dr. h.c. Holger Stark

  60. Medizinische Chemie der L-Typ-Calcium-Kanalblocker: Dihydropyridine und Nicht-Dihydropyridine

    Article • Pharmazie in unserer Zeit, September 2005, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  61. Frontiers in GPCR Research

    Article • Archiv der Pharmazie, June 2005, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  62. Protonenpumpeninhibitoren: Strukturen, Mechanismen und Entwicklungen

    Article • Pharmazie in unserer Zeit, May 2005, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  63. Neue Wirkstoffe zur GERD-Behandlung: Innovationen in der Pipeline

    Article • Pharmazie in unserer Zeit, May 2005, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  64. From Virtual to Real Screening for D3 Dopamine Receptor Ligands

    Article • ChemBioChem, April 2005, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  65. A New Face for Archiv der Pharmazie

    Article • Archiv der Pharmazie, January 2005, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  66. Dedication to H. Schönenberger and Thanks to R. Hartmann

    Article • Archiv der Pharmazie, December 2004, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  67. Medicinal Chemical and Pharmacological Aspects of Imidazole-Containing Histamine H3 Receptor Antagonists

    Article • Mini-Reviews in Medicinal Chemistry, November 2004, Bentham Science Publishers

    Prof. Dr. Dr. h.c. Holger Stark

  68. Hemmstoffe von Beta-Adrenozeptoren: Gemeinsamkeiten und Unterschiede

    Article • Pharmazie in unserer Zeit, November 2004, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  69. Turning from monogamy to strategic promiscuity

    Article • Drug Discovery Today, September 2004, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  70. Wiederaufnahme-Hemmung an der Präsynapse als Wirkprinzip: Medizinische Chemie moderner Antidepressiva— Targets und Arzneistoffe

    Article • Pharmazie in unserer Zeit, July 2004, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  71. H1-Histamines: Development, Structure and Novel Trends

    Article • ChemInform, June 2004, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  72. H1-Antihistaminika: Entwicklungen, Strukturen und neue Tendenzen

    Article • Pharmazie in unserer Zeit, March 2004, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  73. Medizinisch-chemische Aspekte von Statinen: Wirkmechanismus von HMG-CoA-Reduktase-Inhibitoren

    Article • Pharmazie in unserer Zeit, November 2003, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  74. Recent advances in histamine H3/H4receptor ligands

    Article • Expert Opinion on Therapeutic Patents, June 2003, Informa Healthcare

    Prof. Dr. Dr. h.c. Holger Stark

  75. Book Review: Neurotransmitters and Neuromodulators: Handbook of Receptors and Biological Effects, By Oliver von Bohlen und Halbach and Rolf Dermitzel

    Article • ChemBioChem, May 2003, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  76. Neues zum alten Histamin II. Ionenkanäle inDrosophila

    Article • Pharmazie in unserer Zeit, March 2003, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  77. Neues zum alten Histamin I. Ein weiteres Mitglied in der Rezeptorfamilie

    Article • Pharmazie in unserer Zeit, March 2003, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  78. Recent advances in histamine H3/H4 receptor ligands

    Article • Expert Opinion on Therapeutic Patents, January 2003, Informa Healthcare

    Prof. Dr. Dr. h.c. Holger Stark

  79. Dopamine D3 Receptor Ligands with Antagonist Properties

    Article • ChemBioChem, October 2002, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  80. Identification of the dopamine autoreceptor in the guinea-pig retina as D2receptor using novel subtype-selective antagonists

    Article • British Journal of Pharmacology, August 2001, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  81. Separation of chiral 4‐substituted imidazole derivatives by cyclodextrin‐modified capillary electrophoresis

    Article • Biomedical Chromatography, February 2001, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  82. 6 The Histamine H3 Receptor and its Ligands

    Article • Progress in Medicinal Chemistry, January 2001, Elsevier

    Prof. Dr. Dr. h.c. Holger Stark

  83. Separation of chiral 4-substituted imidazole derivatives by cyclodextrin-modified capillary electrophoresis

    Article • Biomedical Chromatography, January 2001, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  84. ChemInform Abstract: Convenient Procedures for Synthesis of Ciproxifan, a Histamine H3-Receptor Antagonist.

    Article • ChemInform, December 2000, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  85. Convenient Procedures for Synthesis of Ciproxifan, a Histamine H3-Receptor Antagonist

    Article • Archiv der Pharmazie, September 2000, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  86. Teil 2: Therapiekonzepte und neue Rezeptorliganden

    Article • Pharmazie in unserer Zeit, July 2000, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  87. Struktur, Funktion und potentielle therapeutische Bedeutung von NMDA-Rezeptoren

    Article • Pharmazie in unserer Zeit, May 2000, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  88. Histamine H3-receptor antagonists inhibit gastroprotection by (R)-α-methylhistamine in the rat

    Article • British Journal of Pharmacology, April 2000, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  89. Iododestannylation: an improved synthesis of [125I]iodoproxyfan, a specific radioligand of the histamine H3 receptor

    Article • Journal of Labelled Compounds, July 1997, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  90. Binding of histamine H3-receptor antagonists to hematopoietic progenitor cells

    Article • FEBS Letters, March 1997, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  91. Computer-Assisted Analysis of Histamine H2− and H3-Receptor Agonists

    Article • QSAR & Combinatorial Science, January 1995, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  92. Azines and Diazines as Potential Histamine H3-Receptor Antagonists

    Article • Archiv der Pharmazie, January 1995, Wiley

    Prof. Dr. Dr. h.c. Holger Stark

  93. Design of histamine H3-receptor agonists and antagonists

    Article • European Journal of Drug Metabolism and Pharmacokinetics, September 1994, Springer Science + Business Media

    Prof. Dr. Dr. h.c. Holger Stark